Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Peter V who wrote (2981)	3/24/1998 9:19:00 PM
From: Bruce Rosen	Read Replies (1) \| Respond to of 7041

I agree, Peter. It will take at least two years for these suits to play out, which is why they are largely irrelevant. If Zonagen files and gets approval, these suits will go away and the stock will soar. If Vasomax doesn't get approval, the stock will suffer with or without these law suits. The risk to the law firms are minimal as there are many to divide the costs. With Zonagen's $70 million cash position, there is more than enough money to entice the attorneys. By the way, I don't view these attorneys as sharks. They play a legitimate role and in some cases, they perform a public service. IMHO, not in this case, however. I believe that future events will show Zonagen to be an honorable and successful company.